StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Merck (MRK) Trades Lower Following AstraZeneca (AZN) Imfinzi Results, Down 0.70%
October 28, 2019 11:39 AM
Merck (NYSE: MRK) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Merck (MRK) Tops Q3 EPS by 27c, Revenues Beat; Narrows & Raises FY19 EPS/Revenue Above Consensus
October 29, 2019 6:47 AM
Mizuho Downplays Merck (MRK) KEYTRUDA Competition in 1L NSCLC
October 28, 2019 12:49 PM
AstraZeneca (AZN) says Imfinzi and Imfinzi plus tremelimumab delayed disease progression in Phase III POSEIDON trial for 1st-line treatment of Stage IV NSCLC
October 28, 2019 11:33 AM
AstraZeneca (AZN) Halted, News Pending
October 28, 2019 11:21 AM
